Kymera Therapeutics, Inc. (KYMR)
83.99
+4.36
(+5.48%)
USD |
NASDAQ |
Dec 19, 16:00
84.08
+0.09
(+0.11%)
After-Hours: 20:00
Kymera Therapeutics Accounts Payable (Quarterly): 5.506M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 808.00M |
| Regeneron Pharmaceuticals, Inc. | 903.80M |
| Cytokinetics, Inc. | 22.08M |
| TG Therapeutics, Inc. | 112.34M |
| Protagonist Therapeutics, Inc. | 5.646M |